BEDFORD, Mass., Jan. 27, 2014 /PRNewswire/ -- Hologic, Inc.
(Hologic or the Company) (NASDAQ: HOLX), a leading developer,
manufacturer and supplier of premium diagnostic products, medical
imaging systems and surgical products, with an emphasis on serving
the healthcare needs of women, will feature its award-winning 3D
mammography (breast tomosynthesis) technology platform as
part of its comprehensive suite of healthcare solutions at the
39th Arab Health Congress 27 January through 30
January at the Dubai International Convention and Exhibition
Centre. With over 3,900 exhibitors, the Arab Health Congress is the
leading educational healthcare conference series in the
Middle East and Northern Africa and one of the largest medical
shows in the world. Arab Health is expected to attract over 80,000
attendees from more than 150 countries this year.
"The Arab Health Congress provides us with the unique
opportunity to highlight our comprehensive suite of imaging,
diagnostic and surgical healthcare solutions in one venue," said
David Harding, Group Senior Vice
President and General Manager, Women's Health. "In 2013, we opened
an office in Dubai strengthening
our presence in this strategic region through enhanced customer
service and improved sales and marketing support for our regional
partners. As a single-source supplier of world-class imaging,
diagnostic and surgical products, we are committed to helping
clinicians identify diseases earlier when the chance of successful
treatment is at its greatest – an enormous benefit to patients and
healthcare systems."
Prominently highlighted at the Congress will be Hologic's 3D
mammography platform including the Selenia Dimensions 3D
mammography system with C-View software. C-View software
allows a 2D image to be constructed from a 3D data set without the
need for a separate 2D x-ray exposure. C-View software is designed
to offer a number of benefits including a reduction in x-ray
exposures leading to shorter exam times (less than 4 second scan
per view), and increased patient comfort from the shorter
compression time. Also featured this year is Hologic's
Affirm 3D mammography biopsy option designed for the
localization and accurate targeting of regions of interest
including targeting lesions not detected with conventional 2D
imaging. This first of its kind biopsy technique provides numerous
advantages over traditional stereotactic biopsy procedures,
including faster lesion targeting and reduced patient procedure
time. The Affirm system is pre-programmed for use with the
Company's Eviva and ATEC vacuum-assisted breast
biopsy devices.
Hologic's 3D mammography offers proven superior clinical
performance compared to 2D alone, with a 40% improvement in
invasive cancer detectioni-iii coupled with a 20-40%
reduction in recall ratesiii-iv. The Company pioneered
the 3D mammography imaging and biopsy market with the introduction
of its Selenia Dimensions 3D system in 2008 and has
placed well over 1,000 3D mammography systems in 59 countries.
Hologic is the only company to have a U.S. Food and Drug
Administration approved 3D mammography system.
Hologic is showcasing two other new commercial products for the
first time at Arab Health. Hologic's Selenia Dimensions Avia
Package offers a lower-cost option for customers seeking a 2D
screening only or 2D screening and diagnostic solution with an
upgrade path to future applications such as 3D mammography. The
Company's Horizon DXA series is designed to offer clinicians
expanded technical capabilities, workflow efficiencies and improved
design components that assist clinicians in the assessment of
critical health problems such as osteoporosis, cardiovascular
disease, body composition and atypical femur fractures.
Also on display will be Hologic's market leading products for
extremity imaging, imaging analytics, GYN surgical and molecular
diagnostics. A sampling of these products includes the
NovaSure system for heavy menstrual bleeding, the
MyoSure system for minimally-invasive fibroid and polyp
removal, the ThinPrep, Cervista and Aptima cervical health
screening products and Panther, the Company's fully
automated molecular testing system. All of Hologic's game-changing
technologies will be exhibited at booths S1B10 in Sheikh
Saeed Hall (imaging products) and
RM50B in the Sheikh Rashid Hall (surgical/diagnostic).
About Hologic, Inc.:
Hologic, Inc. is a leading developer, manufacturer and supplier
of premium diagnostic products, medical imaging systems and
surgical products. The Company operates four core business units
focused on breast health, diagnostics, GYN surgical, and skeletal
health. With a comprehensive suite of technologies and a robust
research and development program, Hologic is committed to improving
lives. The Company is headquartered in Massachusetts. For more information, visit
www.hologic.com.
Hologic, Affirm, Aptima, ATEC, Avia, C-View, Cervista,
Dimensions, Eviva, Horizon, MyoSure, NovaSure, Panther, Selenia and
ThinPrep are trademarks and/or registered trademarks of Hologic,
Inc., and/or its subsidiaries in the
United States and/or other countries.
Forward-Looking Statement Disclaimer:
This News Release may contain forward-looking information that
involves risks and uncertainties, including statements about the
use of Hologic products. There can be no assurance these products
will achieve the benefits described herein and that such benefits
will be replicated in any particular manner with respect to an
individual patient as the actual effect of the use of the products
can only be determined on a case-by-case basis depending on the
particular circumstances and patient in question. Hologic expressly
disclaims any obligation or undertaking to release publicly any
updates or revisions to any such statements presented herein to
reflect any change in expectations or any change in events,
conditions or circumstances on which any such data or statements
are based.
Contacts:
|
|
Marianne
McMorrow
|
Pat Hall
|
Global PR &
Advertising Publicist
|
Director, Corporate
Communications
|
Marianne.mcmorrow@hologic.com
|
Pat.hall@hologic.com
|
Tel:
781.999.7723
|
Tel:
781.999.7463
|
i-iv For references please visit:
http://www.hologic.com/media/2014-Arab-Health-Press-Release-References.pdf
SOURCE Hologic, Inc.